Luminus Management LLC Lucid Diagnostics Inc. Put Options Transaction History
Luminus Management LLC
- $150 Million
- Q2 2024
Put Options
0 transactions
Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
---|
Others Institutions Holding LUCD
# of Institutions
34Shares Held
2.05MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA561KShares$544,0870.0% of portfolio
-
Geode Capital Management, LLC Boston, MA204KShares$198,2240.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT126KShares$122,5710.01% of portfolio
-
Ayrton Capital LLC Westport, CT73.9KShares$71,6893.26% of portfolio
-
Lido Advisors, LLC Los Angeles, CA68KShares$65,9750.0% of portfolio
About Lucid Diagnostics Inc.
- Ticker LUCD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 38,568,500
- Market Cap $37.4M
- Description
- Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company. The company focuses on patients with gastroesophageal reflux disease, which is also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarc...